Avista Capital Partners has announced it has closed on the sale of Inform Diagnostics to Fulgent Genetics for approximately $170 million.
Inform Diagnostics, based in Irving, Texas, is an independent pathology laboratory business that has laboratories in Irving, Texas, as well as Boston, New York City and Phoenix.
Fulgent Genetics (NASDAQ: FLGT), based in Temple City,